The global acute kidney injury treatment market is growing, propelled by the increasing prevalence of chronic diseases such as diabetes, hypertension, etc., across the globe.
The global acute kidney injury treatment market was valued US$ 1,351.70 Mn in 2018. The global acute kidney injury treatment market is expected to witness a cumulative annual growth rate (CAGR) of more than 7% from 2019 to 2027, to reach a value of more than US$ 2,500 Mn by 2027.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67523
Global Acute Kidney Injury Treatment Market: Drivers & Restraints
The global acute kidney injury treatment market is undergoing relatively higher growth, owing to the increasing geriatric patient population, increase in incidences of acute kidney injury cases, and rise in research and development in both, developed and developing markets.
The geriatric population has been increasing, especially in developed countries such as the U.S., most countries in Western Europe, and Japan. Developed countries have high geriatric population vis-à-vis their developing counterparts. This can be ascribed to the improved healthcare infrastructure, favorable reimbursement policies, and advancements in healthcare facilities in developed countries. Moreover, access to various diagnostic and treatment services has improved off late, especially in developed countries. This, in turn, has increased the life expectancy of the population. Studies indicate that, a majority (60%-70%) of the elderly population is more susceptible to acute kidney injury. This is a key factor driving the acute kidney injury treatment market.
Read Report Overview @ https://www.transparencymarketresearch.com/acute-kidney-injury-treatment-market.html
Around 13.3 million people across the globe are estimated to be affected by acute kidney injury. The patient population is expected to rise substantially over the next few decades. Rise in the incidence rate of acute kidney injury is creating a significant socioeconomic impact across the globe.
According to the World Health Organization, the world’s population of people aged 60 years and above is expected to reach more than 2 billion, and that of people aged 80 years and above is likely to reach approximately 400 million by 2050.
Also, factors such as increase in the number of dialysis centers and strong ongoing clinical pipeline are uplifting the growth of the global acute kidney injury treatment market. However, the disappointing result of promising pipeline molecules is expected to restraint the growth of the global acute kidney injury treatment market.
Global Acute Kidney Injury Treatment Market: Segmentation
The global acute kidney injury treatment market is broadly segmented into four categories based on treatment, type, end user, and region.
In terms of treatment, the acute kidney injury treatment market is categorized into dialysis and supportive care.
Supportive care is used to prevent or treat the symptoms of a disease, or side effects caused by the treatment of a disease. It is also called comfort care, palliative care, and symptom management. Supportive care in acute kidney injury treatment includes the correction of electrolyte, fluid management, acid base abnormalities, hematological abnormalities, and medical management.
Based on type, the acute kidney injury treatment market has been classified into prerenal acute kidney injury, postrenal acute kidney injury, and intrinsic renal acute kidney injury. The prerenal acute kidney injury segment held a significant share of the acute kidney injury treatment market in 2018. It is expected to expand at a notable CAGR during the forecast period, led by the prevalence of prerenal acute kidney injuries.
Based on end user, the acute kidney injury treatment market has been segregated into hospitals, ambulatory surgical centers, and others.
Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=67523
Global Acute Kidney Injury Treatment Market: Regional Scenario
Geographically, the global acute kidney injury treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to be a key region in the global acute kidney injury treatment market, and account for a prominent share of the global acute kidney injury treatment market.
North America
The acute kidney injury treatment market in the North America is primarily driven by an increase in the patient population, high incidences and prevalence of chronic diseases, and rising research and development, along with a rise in the number of dialysis centers.
Europe
The acute kidney injury treatment market in Europe is likely to grow at a significant CAGR from 2019 to 2027. Strong ongoing clinical pipeline, presence of key players in the acute kidney injury treatment market in countries such as the Germany, and increase in the number of critical care admissions are expected to boost the growth of the acute kidney injury treatment market in this region.
Asia Pacific
The acute kidney injury treatment market in Asia Pacific is expected to witness high growth during the forecast period. Rapid growth rate in this region is expected due to the presence of a large base of the geriatric population, governmental initiatives taken to improve the healthcare sector, growth in research and development activities, and increasing patient population with acute kidney injuries in the region.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=67523
Global Acute Kidney Injury Treatment Market: Major Players
Rising approvals from government bodies, strong sales and distribution networks, increasing number of technological advancements, rising number of acquisitions and mergers, and increasing research and development are the key trends in the global acute kidney injury treatment market.
Key players operating in global acute kidney injury treatment market and profiled in this report are Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem.
Key Segments in the Global Acute Kidney Injury Treatment Market Report
Importance to various segments has been given in the global acute kidney injury treatment market report. Thus, a detailed breakdown of the type, end-user, and treatment takes up a significant share in this report. In this section, segmentation of the acute kidney injury treatment market based on type, treatment, end user, and region is provided.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com